Coverage
-
October 09, 2018
Gilead Sciences Inc. has asked a Delaware federal court to dismiss yet another patent infringement case against a drugmaker attempting to sell a generic version of its blockbuster HIV preventative medication Truvada, with hints that a settlement is being hammered out.
1 other articles on this case.
View all »